News About: Pharm. Industry
Whanin to sign exclusive distribution agreement for Nalmefene in Korea.Whanin made an exclusive distribution agreement with Biotti Terapis, a biotech company in Finland, on Oct. 26 for the marketing of Nalmefene hydrochloride, an oral anti-alcoholi...
|
Yearly 37 billion won of drug scrapped on overdue shelf lives
Yearly about 37 billion won worth of drugs are scrapped because of the overdue shelf lives, which did not include the disposal expenses at about 16 million won per product.
The Deregulation Reform Council col...
Multinational pharmaceutical firms grab bigger market share
Shares of foreign firms operating in Korea have bulked up over the years, accounting for 72.7 percent of the local reimbursement claims with 1,227 drugs, a lawmaker said citing government statistics.
In a recent p...
Drug code to be integrated for drug safety controls.
All drug safety informations including the adulterated drugs will be provided on an actual time basis through a drug bar code and a pharmacy administration program from 2008 in order to block illegal and adulterated d...
Women thriving in level playing field
As an increasing number of domestic pharmaceutical companies offer a level playing field to job applicants, the ratio of female workers is expected to increase in the years to come, according to pharmaceutical busines...
LG Life Sciences to conduct phase I trial of novel diabetic agent
LG Life Sciences announced on October 25 that it will conduct Phase I test of a new dipeptidyl peptidase IV (LC15-0444) for the treatment of type II diabetes.
In type II diabetes, either the pancreas does not produ...
Korean government criticized for concession on U.S.'s easier marketRepresentatives of the Korea Pharmaceutical Manufacturers Association (KPMA), who held a press conference on October 24 in Seoul, criticized the Korean government for its conces...
|
KPTA calls for well-prepared drug policy in KORUS talks
The Korea Pharmaceutical Manufacturers Association (KPMA) has urged the government to establish more well-prepared drug measure in the ongoing free trade agreement (FTA) talks with the United States, as the government...
Dong-A Pharm to export Zydena to Saudi ArabiaDong-A Pharmaceutical Co. Ltd. said recently it will export Zydena (udenafil), a new phosphodiesterase type 5 (PDE5) inhibitor for erectile dysfunction (ED), to Saudi Arabia.
...
|
Ahngook Pharm to publish Korea version of JACC next monthAhngook Pharm said on October 19 it will publish the first version of the Journal of the American College of Cardiology (JACC), the official journal of the American College of C...
|
